In this issue:
Virtual reality-based cognitive remediation therapy
Speech features & symptom severity
Economic burden of metabolic comorbidities in schizophrenia
LB-102: a novel antipsychotic in acute schizophrenia
Timing of domain improvements in schizophrenia
Metformin vs. GLP-1RAs to prevent diabetes following antipsychotics
Functional brain alterations, cognitive impairment & MATRICS domains
Burden of tardive dyskinesia in schizophrenia
Stressful life events & clinical outcomes in first-episode psychosis
Progressive clozapine dose reductions in remitted treatment-resistant schizophrenia
Please login below to download this issue (PDF)